A detailed history of Geode Capital Management, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,815,710 shares of TXG stock, worth $28.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,815,710
Previous 1,772,933 2.41%
Holding current value
$28.7 Million
Previous $34.5 Million 18.89%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.71 - $23.49 $672,026 - $1 Million
42,777 Added 2.41%
1,815,710 $41 Million
Q2 2024

Aug 09, 2024

BUY
$19.45 - $37.37 $2.52 Million - $4.85 Million
129,780 Added 7.9%
1,772,933 $34.5 Million
Q1 2024

May 13, 2024

BUY
$36.08 - $54.3 $2 Million - $3 Million
55,338 Added 3.49%
1,643,153 $61.7 Million
Q4 2023

Feb 13, 2024

BUY
$34.32 - $57.55 $2.36 Million - $3.96 Million
68,771 Added 4.53%
1,587,815 $88.9 Million
Q3 2023

Nov 13, 2023

BUY
$40.86 - $62.98 $3.44 Million - $5.31 Million
84,243 Added 5.87%
1,519,044 $62.7 Million
Q2 2023

Aug 11, 2023

BUY
$50.96 - $58.72 $3.51 Million - $4.05 Million
68,905 Added 5.04%
1,434,801 $80.1 Million
Q1 2023

May 15, 2023

BUY
$35.33 - $55.79 $1.58 Million - $2.49 Million
44,662 Added 3.38%
1,365,896 $76.2 Million
Q4 2022

Feb 13, 2023

BUY
$24.4 - $41.3 $1.55 Million - $2.62 Million
63,324 Added 5.03%
1,321,234 $48.1 Million
Q3 2022

Nov 14, 2022

BUY
$28.48 - $52.59 $1.09 Million - $2.02 Million
38,393 Added 3.15%
1,257,910 $35.8 Million
Q2 2022

Aug 12, 2022

BUY
$36.95 - $82.41 $1.15 Million - $2.56 Million
31,078 Added 2.62%
1,219,517 $55.2 Million
Q1 2022

May 13, 2022

BUY
$55.7 - $145.79 $1.61 Million - $4.23 Million
28,984 Added 2.5%
1,188,439 $90.3 Million
Q4 2021

Feb 11, 2022

BUY
$135.05 - $182.59 $4.15 Million - $5.61 Million
30,714 Added 2.72%
1,159,455 $173 Million
Q3 2021

Nov 12, 2021

BUY
$145.58 - $192.14 $17.4 Million - $22.9 Million
119,254 Added 11.81%
1,128,741 $164 Million
Q2 2021

Aug 13, 2021

BUY
$134.22 - $202.37 $14.5 Million - $21.8 Million
107,662 Added 11.94%
1,009,487 $197 Million
Q1 2021

May 12, 2021

BUY
$140.25 - $196.86 $15.9 Million - $22.4 Million
113,719 Added 14.43%
901,825 $163 Million
Q4 2020

Feb 12, 2021

BUY
$126.47 - $163.7 $12.9 Million - $16.8 Million
102,357 Added 14.93%
788,106 $111 Million
Q3 2020

Nov 13, 2020

BUY
$87.44 - $125.0 $33.4 Million - $47.7 Million
381,564 Added 125.44%
685,749 $85.5 Million
Q2 2020

Aug 13, 2020

BUY
$58.39 - $89.31 $11.6 Million - $17.7 Million
198,559 Added 187.98%
304,185 $27.2 Million
Q1 2020

May 14, 2020

BUY
$51.57 - $106.62 $812,433 - $1.68 Million
15,754 Added 17.53%
105,626 $6.58 Million
Q4 2019

Feb 13, 2020

BUY
$46.07 - $79.54 $4.14 Million - $7.15 Million
89,872 New
89,872 $6.85 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.